|
[1]
|
A Simple and Rapid HPLC Method Development for Quantification of Sodium Benzoate Content in Chlorzoxazone Oral Solid Dosage Forms
Biomedical Chromatography,
2025
DOI:10.1002/bmc.6048
|
|
|
|
|
[2]
|
Development and Validation of an Eco-Friendly HPLC Stability-Indicating Technique for Quantification of Atropine Sulfate and Benzyl Alcohol in Raw and Injectable Solutions
ACS Omega,
2025
DOI:10.1021/acsomega.5c06752
|
|
|
|
|
[3]
|
Molecular Modeling, Synthesis, and Antihyperglycemic Activity of the New Benzimidazole Derivatives – Imidazoline Receptor Agonists
Drug Design, Development and Therapy,
2024
DOI:10.2147/DDDT.S447289
|
|
|
|
|
[4]
|
Eco-Friendly Stability-Indicating HPLC Method for Related Compounds in Pemetrexed Ditromethamine (Antineoplastic Agent) for Injection
Journal of AOAC International,
2024
DOI:10.1093/jaoacint/qsae008
|
|
|
|
|
[5]
|
Evaluation of the Greenness, Whiteness, and blueness profiles of stability indicating HPLC method for determination of Denaverine hydrochloride and benzyl alcohol in pharmaceuticals
Microchemical Journal,
2024
DOI:10.1016/j.microc.2024.110733
|
|
|
|
|
[6]
|
A validated stability‐indicating reversed‐phase‐UPLC method for simultaneous estimation of promethazine hydrochloride, methylparaben, propylparaben and sodium benzoate assay of cough suppressant and antihistamine liquid oral dosage forms
Biomedical Chromatography,
2024
DOI:10.1002/bmc.5944
|
|
|
|
|
[7]
|
A Novel, Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Assay and Organic Impurities of Pyridostigmine Bromide and Assay of Sodium Benzoate in Liquid Oral Formulation
Pharmaceutical Chemistry Journal,
2024
DOI:10.1007/s11094-024-03279-8
|
|
|
|
|
[8]
|
A stability‐indicating, reversed‐phase HPLC method for quantification of assay and organic impurities in doxycycline hyclate bulk and parenteral dosage forms
Biomedical Chromatography,
2023
DOI:10.1002/bmc.5626
|
|
|
|
|
[9]
|
A validated stability‐indicating reversed‐phase liquid chromatography method for the quantification of Ixabepilone (Oncology drug) in the parenteral dosage form
SEPARATION SCIENCE PLUS,
2023
DOI:10.1002/sscp.202200099
|
|
|
|
|
[10]
|
Development of HPLC Method for Ixabepilone (Oncology Drug) in Bulk and Dosage Form: Quantification of Impurities and Forced Degradation Studies
Journal of Chromatographic Science,
2023
DOI:10.1093/chromsci/bmad049
|
|
|
|
|
[11]
|
Development and validation of reversed-phase-HPLC method for simultaneous quantification of fulvestrant and disulfiram in liposomes
Bioanalysis,
2023
DOI:10.4155/bio-2023-0137
|
|
|
|